CRISPR editing of sftb-1/SF3B1 in Caenorhabditis elegans allows the identification of synthetic interactions with cancer-related mutations and the chemical inhibition of splicing

SF3B1 is the most frequently mutated splicing factor in cancer. Mutations in SF3B1 likely confer clonal advantages to cancer cells but they may also confer vulnerabilities that can be therapeutically targeted. SF3B1 cancer mutations can be maintained in homozygosis in C. elegans, allowing synthetic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS Genet
Autors principals: Serrat, Xènia, Kukhtar, Dmytro, Cornes, Eric, Esteve-Codina, Anna, Benlloch, Helena, Cecere, Germano, Cerón, Julián
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6830814/
https://ncbi.nlm.nih.gov/pubmed/31634348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1008464
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars